搜狐1 个月
Regenity 交联胶原膜片获批准，临床数据表明其在牙科手术中优势明显
Regenity 新型交联膜片(Matrixflex)在一项为期6个月的多中心随机对照试验中接受了评估，中国六家主要医院的174名患者参加了试验，该试验针对骨移植和引导组织再生(GTR)的效果，对Regenity 新型交联膜片和 Geistlich 非交联 Bio-Gide 胶原膜片进行了比较。 该研究得出结论 ...
TMCnet1 个月
Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China ...
Multicenter Clinical Study Demonstrates Benefits of Regenity's Novel Crosslinked Collagen Membrane Compared to Geistlich Bio-Gide ® Collagen Membrane and Enables Launch into China PARAMUS, N.J., Sept.
Regenity Biosciences 完成首次突破性临床研究，其胶原牙科膜片获得中国 ...
多中心临床研究表明，与 Geistlich Bio-Gide ® 胶原膜片相比，Regenity 的新型交联胶原膜片具有更多优势，并有望在中国上市 ...
Yahoo Finance1 个月
Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China ...
Multicenter Clinical Study Demonstrates Benefits of Regenity's Novel Crosslinked Collagen Membrane Compared to Geistlich Bio-Gide ® Collagen Membrane and Enables Launch into China PARAMUS ...